|
|
|
|
|
|
by 0x12
5362 days ago
|
|
|
That all depends on the price. If the price is reasonable then fine. But typically big pharma that gets a lock-in on 'life' is anything but reasonable in their pricing, after all, what's the value of a human life. The 5% profits over costs is promising, even if it leaves some wiggle room. |
|
|